Physician profile
John T Crane
NPI 1811978281
$415,241.89
in general payments reported to CMS, 2019-2025
7 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $84K · 2021: $69K · 2022: $85K · 2023: $100K · 2024: $40K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $105K · Travel and Lodging: $27K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $4,240 · Gift: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $104,760.00 |
| Travel and Lodging | $27,379.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,141.00 |
| Food and Beverage | $4,239.70 |
| Gift | $244.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $378,212.79 | 2019-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $34,121.92 | 2019-2025 | Upsylon, Obtryx System - Curved, Solyx Sis System |
| Medtronic, INC. | $2,704.03 | 2021-2025 | Interstim |
| Coloplast Corp | $97.26 | 2021 | |
| Medtronic USA, INC. | $79.69 | 2019 | |
| Axonics, INC. | $13.19 | 2021 | |
| Allergan, INC. | $13.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Crane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.